Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-01-06

Clinical Trial Update: The Metabolism Research of KLK Treating Acute Cerebral Ischemic Stroke: Focus on Drug Frequency-Efficacy Relationship [NA]

View source ↗

Summary

A clinical trial update investigating KLK as a treatment for acute cerebral ischemic stroke, focusing on how dosing frequency relates to efficacy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • KLK

Snippet

Sponsor: Huisheng Chen | Conditions: Cerebral Infarction | NA | Status: UNKNOWN